NCT06068153 2024-11-20
AMBER
ETOP IBCSG Partners Foundation
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT04875585 2022-08-24
INNWOP1
Medical University Innsbruck
Phase 2 Recruiting
NCT04989322 2021-12-08
Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC
The University of Hong Kong
Phase 2 Unknown
NCT01529112 2017-09-26
A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments
Eisai Inc.
Phase 2 Completed